Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Global absence and targeting of protective immune states in severe COVID-19

Open access
Combes, Alexis J., Courau, Tristan, Kuhn, Nicholas F., Hu, Kenneth H., Ray, Arja, Chen, William S., Chew, Nayvin W., Cleary, Simon J., Kushnoor, Divyashree, Reeder, Gabriella C., Shen, Alan, Tsui, Jessica, Hiam-Galvez, Kamir J., Muñoz-Sandoval, Priscila, Zhu, Wandi S., Lee, David S., Sun, Yang, You, Ran, Magnen, Mélia, Rodriguez, Lauren, Im, K. W., Serwas, Nina K., Leligdowicz, Aleksandra, Zamecnik, Colin R., Loudermilk, Rita P., Wilson, Michael R., Ye, Chun J., Fragiadakis, Gabriela K., Looney, Mark R., Chan, Vincent, Ward, Alyssa, Carrillo, Sidney, The UCSF COMET Consortium, Cathy, Cai, Zhan, Jenny, Samad, Bushra, Chak, Suzanna, Ghale, Rajani, Giberson, Jeremy, Gonzalez, Ana, Jauregui, Alejandra, Lee, Deanna, Nguyen, Viet, Yee, Kimberly, Abe-Jones, Yumiko, Pierce, Logan, Prasad, Priya, Sinha, Pratik, Beagle, Alexander, Lea, Tasha, Esmalii, Armond, Sigman, Austin, Ortiz, Gabriel M., Raffel, Kattie, Jones, Chayse, Liu, Kathleen, Eckalbar, Walter, Matthay, Michael, Erle, David J., Woodruff, Prescott G., Langelier, Charles, Kangelaris, Kirsten, Hendrickson, Carolyn M., Calfee, Carolyn, Rao, Arjun Arkal, Krummel, Matthew F.·2021·Nature

Abstract

Although infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has pleiotropic and systemic effects in some individuals1–3, many others experience milder symptoms. Here, to gain a more comprehensive understanding of the distinction between severe and mild phenotypes in the pathology of coronavirus disease 2019 (COVID-19) and its origins, we performed a whole-blood-preserving single-cell analysis protocol to integrate contributions from all major immune cell types of the blood—including neutrophils, monocytes, platelets, lymphocytes and the contents of the serum. Patients with mild COVID-19 exhibit a coordinated pattern of expression of interferon-stimulated genes (ISGs)3 across every cell population, whereas these ISG-expressing cells are systemically absent in patients with severe disease. Paradoxically, individuals with severe COVID-19 produce very high titres of anti-SARS-CoV-2 antibodies and have a lower viral load compared to individuals with mild disease. Examination of the serum from patients with severe COVID-19 shows that these patients uniquely produce antibodies that functionally block the production of the ISG-expressing cells associated with mild disease, by activating conserved signalling circuits that dampen cellular responses to interferons. Overzealous antibody responses pit the immune system against itself in many patients with COVID-19, and perhaps also in individuals with other viral infections. Our findings reveal potential targets for immunotherapies in patients with severe COVID-19 to re-engage viral defence. Patients with mild COVID-19 show a pattern of interferon-stimulated gene (ISG) expression across all major cell types, but in patients with severe disease, antibodies block the production of these ISG-expressing cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-021-03234-7

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 256

Metadata

Authors
Combes, A. J., Courau, T., Kuhn, N. F., Hu, K. H., Ray, A., Chen, W. S., Chew, N. W., Cleary, S. J., Kushnoor, D., Reeder, G. C., Shen, A., Tsui, J., Hiam-Galvez, K. J., Muñoz-Sandoval, P., Zhu, W. S., Lee, D. S., Sun, Y., You, R., Magnen, M., Rodriguez, L., Im, K. W., Serwas, N. K., Leligdowicz, A., Zamecnik, C. R., Loudermilk, R. P., Wilson, M. R., Ye, C. J., Fragiadakis, G. K., Looney, M. R., Chan, V., Ward, A., Carrillo, S., The UCSF COMET Consortium, Cathy, C., Zhan, J., Samad, B., Chak, S., Ghale, R., Giberson, J., Gonzalez, A., Jauregui, A., Lee, D., Nguyen, V., Yee, K., Abe-Jones, Y., Pierce, L., Prasad, P., Sinha, P., Beagle, A., Lea, T., Esmalii, A., Sigman, A., Ortiz, G. M., Raffel, K., Jones, C., Liu, K., Eckalbar, W., Matthay, M., Erle, D. J., Woodruff, P. G., Langelier, C., Kangelaris, K., Hendrickson, C. M., Calfee, C., Rao, A. A., & Krummel, M. F.
Venue
Nature
Published
2021-01-25
Volume
591
Issue
7848
Pages
124-130
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3121478780
Cited by
256
References
42
FWCI
16.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global absence and targeting of protective immune states in severe COVID-19. https://app.cochat.ai/papers/10.1038/s41586-021-03234-7
The paper
Combes, A. J., Courau, T., Kuhn, N. F., Hu, K. H., Ray, A., Chen, W. S., Chew, N. W., Cleary, S. J., Kushnoor, D., Reeder, G. C., Shen, A., Tsui, J., Hiam-Galvez, K. J., Muñoz-Sandoval, P., Zhu, W. S., Lee, D. S., Sun, Y., You, R., Magnen, M., . . . Krummel, M. F. (2021). Global absence and targeting of protective immune states in severe COVID-19. Nature. https://doi.org/10.1038/s41586-021-03234-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.